Stocks and Investing Stocks and Investing
Fri, February 24, 2023

Jayson Bedford Maintained (TNDM) at Buy with Decreased Target to $47 on, Feb 24th, 2023


Published on 2024-10-28 01:52:05 - WOPRAI, Jayson Bedford
  Print publication without navigation


Jayson Bedford of Raymond James, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Decreased Target from $52 to $47 on, Feb 24th, 2023.

Jayson has made no other calls on TNDM in the last 4 months.



There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 3 agree with Jayson's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeff Johnson of "Baird" Maintained at Hold with Decreased Target to $40 on, Thursday, February 23rd, 2023
  • Mike Polark of "Wolfe Research" Initiated at Hold on, Thursday, January 26th, 2023
  • Larry Biegelsen of "Wells Fargo" Upgraded from Sell to Hold and Held Target at $43 on, Tuesday, November 15th, 2022


These are the ratings of the 2 analyists that currently disagree with Jayson


  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Decreased Target to $52 on, Thursday, February 23rd, 2023
  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $50 on, Thursday, February 23rd, 2023
Contributing Sources